244 related articles for article (PubMed ID: 15938925)
41. [Study on the prognostic factors of colorectal cancer after radical resection and on suggested model for prediction].
Yang YF; Li PZ; Liang XB; Han XL; Li YP; Cong J
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Mar; 26(3):214-7. PubMed ID: 15941514
[TBL] [Abstract][Full Text] [Related]
42. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
43. Analysis of urinary nucleosides. IV. Identification of urinary purine nucleosides by liquid chromatography/electrospray mass spectrometry.
Dudley E; Lemière F; Van Dongen W; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
Rapid Commun Mass Spectrom; 2004; 18(22):2730-8. PubMed ID: 15499664
[TBL] [Abstract][Full Text] [Related]
44. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
[TBL] [Abstract][Full Text] [Related]
45. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
46. Short-term moderate exercise programs reduce oxidative DNA damage as determined by high-performance liquid chromatography-electrospray ionization-mass spectrometry in patients with colorectal carcinoma following primary treatment.
Allgayer H; Owen RW; Nair J; Spiegelhalder B; Streit J; Reichel C; Bartsch H
Scand J Gastroenterol; 2008 Aug; 43(8):971-8. PubMed ID: 18609189
[TBL] [Abstract][Full Text] [Related]
47. Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma.
Djukovic D; Baniasadi HR; Kc R; Hammoud Z; Raftery D
Rapid Commun Mass Spectrom; 2010 Oct; 24(20):3057-62. PubMed ID: 20872639
[TBL] [Abstract][Full Text] [Related]
48. Quantitation of urinary nucleosides by high-performance liquid chromatography.
Liebich HM; Di Stefano C; Wixforth A; Schmid HR
J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
[TBL] [Abstract][Full Text] [Related]
49. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
[TBL] [Abstract][Full Text] [Related]
50. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
Grossmann I; de Bock GH; Meershoek-Klein Kranenbarg WM; van de Velde CJ; Wiggers T
Eur J Surg Oncol; 2007 Mar; 33(2):183-7. PubMed ID: 17174516
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.
Cho SH; Choi MH; Lee WY; Chung BC
Clin Biochem; 2009 Apr; 42(6):540-3. PubMed ID: 19186175
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
53. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
[TBL] [Abstract][Full Text] [Related]
54. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
[TBL] [Abstract][Full Text] [Related]
55. A paradox explained? Patients with delayed diagnosis of symptomatic colorectal cancer have good prognosis.
Rupassara KS; Ponnusamy S; Withanage N; Milewski PJ
Colorectal Dis; 2006 Jun; 8(5):423-9. PubMed ID: 16684087
[TBL] [Abstract][Full Text] [Related]
56. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of plasma D-dimer levels in patients with colorectal cancer.
Kilic M; Yoldas O; Keskek M; Ertan T; Tez M; Gocmen E; Koc M
Colorectal Dis; 2008 Mar; 10(3):238-41. PubMed ID: 17868411
[TBL] [Abstract][Full Text] [Related]
58. Classification of lung cancer patients and controls by chromatography of modified nucleosides in serum.
McEntire JE; Kuo KC; Smith ME; Stalling DL; Richens JW; Zumwalt RW; Gehrke CW; Papermaster BW
Cancer Res; 1989 Feb; 49(4):1057-62. PubMed ID: 2912551
[TBL] [Abstract][Full Text] [Related]
59. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
60. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
